Cargando…

Strategies for targeting the DNA damage response for cancer therapeutics

The DNA damage response is critical for cells to maintain genome stability and survival. In this review, we discuss approaches to targeting critical elements of the DNA damage response for radiosensitization and chemosensitization. In addition, we also discuss strategies for targeting DNA damage res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dan, Wang, Hai-Bo, Brinkman, Kathryn L., Han, Su-Xia, Xu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777509/ https://www.ncbi.nlm.nih.gov/pubmed/22704491 http://dx.doi.org/10.5732/cjc.012.10087

Ejemplares similares

Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

DNA Damage Response
por: Oksenych, Valentyn, et al.
Publicado: (2021)

Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing
por: Agarwal, Ashok, et al.
Publicado: (2017)

Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
por: Padella, Antonella, et al.
Publicado: (2022)

Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma
por: Lei, Huimin, et al.
Publicado: (2022)

DNA Damage Response (DDR) and DNA Repair
por: Vernì, Fiammetta
Publicado: (2022)

Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
por: Minchom, Anna, et al.
Publicado: (2018)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021)

Precision medicine meets the DNA damage response in pancreatic cancer
por: Perkhofer, Lukas, et al.
Publicado: (2018)

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
por: Im, Joo-Young, et al.
Publicado: (2023)

The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
por: Bouberhan, Sara, et al.
Publicado: (2023)

DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer
por: Zhu, Zhongling, et al.
Publicado: (2018)

DNA Damage Response Mechanisms in Model Systems
por: LaRocque, Jeannine R., et al.
Publicado: (2023)

SUMO in the DNA damage response
por: Hendriks, Ivo A., et al.
Publicado: (2015)

The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response
por: Coleman, Niamh, et al.
Publicado: (2020)

Progress in therapeutic strategies based on cancer lipid metabolism
por: Diao, Xia‐Yao, et al.
Publicado: (2019)

The Cellular Response to DNA Damage: From DNA Repair to Polyploidy and Beyond
por: Mirzayans, Razmik
Publicado: (2023)

DNA Damage, Repair, and Cancer Metabolism
por: Kang, Tae-Hong
Publicado: (2023)

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
por: Lazo, Pedro A.
Publicado: (2022)

Special Issue “DNA Replication/Repair, and the DNA Damage Response in Human Disease”
por: Zhang, Dong, et al.
Publicado: (2023)

Targeting DNA Damage Response as a Strategy to Treat HPV Infections
por: Banerjee, N. Sanjib, et al.
Publicado: (2019)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Targeting the DNA damage response for cancer therapy
por: Curtin, Nicola J.
Publicado: (2023)

Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)

Neurovascular unit protection—novel therapeutic targets and strategies
por: Chen, Chen, et al.
Publicado: (2021)

Chemically-Induced DNA Damage, Mutagenesis, and Cancer
por: Basu, Ashis K., et al.
Publicado: (2018)

A special issue on DNA damage response and genome stability
por: Li, Guo-Min
Publicado: (2012)

Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose
por: Peiris-Pagès, Maria, et al.
Publicado: (2015)

DNA Damage, Mutagenesis, and DNA Repair
por: Basu, Ashis, et al.
Publicado: (2010)

Novel Targets and Therapeutic Strategies for Promoting Organ Repair and Regeneration
por: Muruganandan, Shanmugam, et al.
Publicado: (2020)

New Therapeutic Strategies for Lung Cancer
por: Icard, Philippe, et al.
Publicado: (2021)

The telomere protein tankyrase 1 regulates DNA damage responses at telomeres
por: Chang, Sandy
Publicado: (2010)

Targeting the epigenetics of the DNA damage response in breast cancer
por: Montenegro, M F, et al.
Publicado: (2016)

Targeting DNA Damage Response in Prostate and Breast Cancer
por: Wengner, Antje M., et al.
Publicado: (2020)

MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
por: Wang, Yaqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ue81pibg0errpagdp2g7fdm9f